Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)
CNY 7.23
(-0.41%)
CNY 7.23
(-0.41%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.49 Million CNY | -19.08% |
| 2022 | 1.84 Million CNY | -55.57% |
| 2021 | 4.15 Million CNY | 111545803603967900.0% |
| 2020 | - CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 1.00 CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 360 Million CNY | 0.11% |
| 2015 | 359.59 Million CNY | 0.44% |
| 2014 | 358.02 Million CNY | 0.42% |
| 2013 | 356.53 Million CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 6473.00 CNY | 0.0% |
| 2024 Q2 | 1.51 Million CNY | -100.0% |
| 2024 Q1 | 1.5 Million CNY | 100.0% |
| 2023 Q2 | 1.66 Million CNY | -0.57% |
| 2023 Q3 | 1.65 Million CNY | -0.82% |
| 2023 FY | 1.49 Million CNY | -19.08% |
| 2023 Q4 | 1.49 Million CNY | -9.72% |
| 2023 Q1 | 1.67 Million CNY | -9.11% |
| 2022 Q3 | 2.14 Million CNY | -25.98% |
| 2022 Q2 | 2.9 Million CNY | -17.83% |
| 2022 FY | 1.84 Million CNY | -55.57% |
| 2022 Q1 | 3.53 Million CNY | -14.95% |
| 2022 Q4 | 1.84 Million CNY | -14.11% |
| 2021 Q3 | 3.27 Million CNY | 21.65% |
| 2021 FY | 4.15 Million CNY | 111545803603967900.0% |
| 2021 Q2 | 2.69 Million CNY | 57.66% |
| 2021 Q1 | 1.7 Million CNY | 45867432148991900.0% |
| 2021 Q4 | 4.15 Million CNY | 26.79% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q4 | - CNY | -100.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | - CNY | 0.0% |
| 2020 Q3 | 1.00 CNY | 0.0% |
| 2019 Q4 | - CNY | 100.0% |
| 2019 FY | - CNY | -100.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 Q2 | 1.00 CNY | 0.0% |
| 2018 Q3 | - CNY | -100.0% |
| 2018 Q4 | 1.00 CNY | 6710886400.0% |
| 2018 FY | 1.00 CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | -100.0% |
| 2017 Q1 | 360 Million CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2017 Q4 | - CNY | -100.0% |
| 2017 Q3 | 1.00 CNY | 0.0% |
| 2016 Q3 | 360 Million CNY | 0.0% |
| 2016 Q1 | 360 Million CNY | 0.11% |
| 2016 Q4 | 360 Million CNY | 0.0% |
| 2016 Q2 | 360 Million CNY | 0.0% |
| 2016 FY | 360 Million CNY | 0.11% |
| 2015 Q3 | 359.19 Million CNY | 0.11% |
| 2015 Q4 | 359.59 Million CNY | 0.11% |
| 2015 Q1 | 358.39 Million CNY | 0.11% |
| 2015 FY | 359.59 Million CNY | 0.44% |
| 2015 Q2 | 358.79 Million CNY | 0.11% |
| 2014 Q2 | 357.26 Million CNY | 0.11% |
| 2014 Q3 | 357.64 Million CNY | 0.11% |
| 2014 Q4 | 358.02 Million CNY | 0.11% |
| 2014 FY | 358.02 Million CNY | 0.42% |
| 2014 Q1 | 356.88 Million CNY | 0.1% |
| 2013 FY | 356.53 Million CNY | 0.0% |
| 2013 Q1 | 355.44 Million CNY | 0.0% |
| 2013 Q4 | 356.53 Million CNY | 0.1% |
| 2013 Q2 | 355.82 Million CNY | 0.1% |
| 2013 Q3 | 356.17 Million CNY | 0.1% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 Q1 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2009 Q3 | - CNY | 0.0% |
| 2009 Q1 | - CNY | 0.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2008 Q4 | - CNY | 0.0% |
| 2008 Q3 | - CNY | 0.0% |
| 2008 Q1 | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2008 Q2 | - CNY | 0.0% |
| 2007 Q4 | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |